يعرض 1 - 20 نتائج من 45 نتيجة بحث عن '"interleukin 2/ec [Endogenous Compound]"', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 1
    Electronic Resource

    مصطلحات الفهرس: kidney function, kidney tubule cell, kidney tubule necrosis, macrophage migration, male, mouse, mRNA expression level, myofibroblast, neutrophil chemotaxis, nonhuman, primary culture, renal ischemia reperfusion injury, renal protection, alpha smooth muscle actin/ec [Endogenous Compound], buprenorphine/sc [Subcutaneous Drug Administration], carprofen/sc [Subcutaneous Drug Administration], CD68 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cyclophilin/ec [Endogenous Compound], cyclophilin A/ec [Endogenous Compound], cyclophilin D/ec [Endogenous Compound], cyclophilin inhibitor/cr [Drug Concentration], cyclophilin inhibitor/do [Drug Dose], cyclophilin inhibitor/dt [Drug Therapy], cyclophilin inhibitor/po [Oral Drug Administration], cyclophilin inhibitor/pd [Pharmacology], interleukin 2/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], oxygen radical, platelet derived growth factor B/ec [Endogenous Compound], stress activated protein kinase/ec [Endogenous Compound], transforming growth factor beta1/ec [Endogenous Compound], tubulin, tumor necrosis factor/ec [Endogenous Compound], unclassified drug, gs 642362/cr [Drug Concentration], gs 642362/do [Drug Dose], gs 642362/dt [Drug Therapy], gs 642362/po [Oral Drug Administration], gs 642362/pd [Pharmacology], ureter obstruction, acute kidney failure/dt [Drug Therapy], animal cell, animal experiment, animal model, animal tissue, article, cell death, controlled study, dose response, drug blood level, drug dose comparison, drug efficacy, EC90, enzyme inhibition, experimental renal failure, glomerulus capillary, immunohistochemistry, in vivo study, kidney fibrosis/dt [Drug Therapy], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28557
    International Journal of Molecular Sciences
    Click here for full text options
    LibKey Link

  2. 2
    Electronic Resource

    مصطلحات الفهرس: kidney function, kidney tubule cell, kidney tubule necrosis, macrophage migration, male, mouse, mRNA expression level, myofibroblast, neutrophil chemotaxis, nonhuman, primary culture, renal ischemia reperfusion injury, renal protection, alpha smooth muscle actin/ec [Endogenous Compound], buprenorphine/sc [Subcutaneous Drug Administration], carprofen/sc [Subcutaneous Drug Administration], CD68 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cyclophilin/ec [Endogenous Compound], cyclophilin A/ec [Endogenous Compound], cyclophilin D/ec [Endogenous Compound], cyclophilin inhibitor/cr [Drug Concentration], cyclophilin inhibitor/do [Drug Dose], cyclophilin inhibitor/dt [Drug Therapy], cyclophilin inhibitor/po [Oral Drug Administration], cyclophilin inhibitor/pd [Pharmacology], interleukin 2/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], oxygen radical, platelet derived growth factor B/ec [Endogenous Compound], stress activated protein kinase/ec [Endogenous Compound], transforming growth factor beta1/ec [Endogenous Compound], tubulin, tumor necrosis factor/ec [Endogenous Compound], unclassified drug, gs 642362/cr [Drug Concentration], gs 642362/do [Drug Dose], gs 642362/dt [Drug Therapy], gs 642362/po [Oral Drug Administration], gs 642362/pd [Pharmacology], ureter obstruction, acute kidney failure/dt [Drug Therapy], animal cell, animal experiment, animal model, animal tissue, article, cell death, controlled study, dose response, drug blood level, drug dose comparison, drug efficacy, EC90, enzyme inhibition, experimental renal failure, glomerulus capillary, immunohistochemistry, in vivo study, kidney fibrosis/dt [Drug Therapy], Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28557
    International Journal of Molecular Sciences
    LibKey Link

  3. 3
    Electronic Resource
  4. 4
    Electronic Resource
  5. 5
    Electronic Resource
  6. 6
    Electronic Resource
  7. 7
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36888
    Journal of Cellular and Molecular Medicine
    Click here for full text options
    LibKey Link

  8. 8
    Electronic Resource
  9. 9
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36888
    Journal of Cellular and Molecular Medicine
    Click here for full text options
    LibKey Link

  10. 10
    Electronic Resource
  11. 11
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38858
    Immunology
    Click here for full text options
    LibKey Link

  12. 12
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38858
    Immunology
    Click here for full text options
    LibKey Link

  13. 13
    Electronic Resource
  14. 14
    Electronic Resource
  15. 15
    Electronic Resource
  16. 16
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27514
    Click here for full text options
    LibKey Link

  17. 17
    Electronic Resource

    المؤلفون: Shortt J., Johnstone R.W., Hsu A.K.

    مصطلحات الفهرس: gene control, gene expression profiling, haploinsufficiency, human, intracellular signaling, lymphocyte proliferation, molecularly targeted therapy, myelodysplastic syndrome, neutropenia/si [Side Effect], nonhuman, oxidative stress, peripheral neuropathy/si [Side Effect], phenotype, priority journal, progression free survival, protein expression, protein phosphorylation, review, RNA translation, second cancer, septic shock, signal transduction, single nucleotide polymorphism, stem cell mobilization, thrombocytopenia/si [Side Effect], tumor immunity, upregulation, bortezomib/cb [Drug Combination], carfilzomib, CD28 antigen/ec [Endogenous Compound], cyclooxygenase 2, fibroblast growth factor 2/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], initiation factor 4E/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 2/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], lenalidomide/ae [Adverse Drug Reaction], myeloid differentiation factor 88/ec [Endogenous Compound], phosphatidylinositol 3 kinase/ec [Endogenous Compound], pomalidomide/ae [Adverse Drug Reaction], protein kinase C/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], suppressor of cytokine signaling/ec [Endogenous Compound], thalidomide/ae [Adverse Drug Reaction], thalidomide/cb [Drug Combination], thalidomide/cr [Drug Concentration], thalidomide/ip [Intraperitoneal Drug Administration], thalidomide/po [Oral Drug Administration], transcription factor Fli 1/ec [Endogenous Compound], transcription factor NFAT/ec [Endogenous Compound], transcription factor PU 1/ec [Endogenous Compound], transcription factor Sp1/ec [Endogenous Compound], Tumor necrosis factor alpha, vasculotropin/ec [Endogenous Compound], voltage gated chloride channel/ec [Endogenous Compound], large cell lymphoma, 5'-untranslated region, angiogenesis, antiangiogenic activity, antibody dependent cellular cytotoxicity, antiinflammatory activity, arachidonic acid metabolism, cell differentiation, chromosome 5, chromosome 5q, conceptual framework, drug blood level, drug dose escalation, embryotoxicity, epigenetics, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42642
    Click here for full text options
    LibKey Link

  18. 18
    Electronic Resource

    المؤلفون: Shortt J., Johnstone R.W., Hsu A.K.

    مصطلحات الفهرس: gene control, gene expression profiling, haploinsufficiency, human, intracellular signaling, lymphocyte proliferation, molecularly targeted therapy, myelodysplastic syndrome, neutropenia/si [Side Effect], nonhuman, oxidative stress, peripheral neuropathy/si [Side Effect], phenotype, priority journal, progression free survival, protein expression, protein phosphorylation, review, RNA translation, second cancer, septic shock, signal transduction, single nucleotide polymorphism, stem cell mobilization, thrombocytopenia/si [Side Effect], tumor immunity, upregulation, bortezomib/cb [Drug Combination], carfilzomib, CD28 antigen/ec [Endogenous Compound], cyclooxygenase 2, fibroblast growth factor 2/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], initiation factor 4E/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 2/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], lenalidomide/ae [Adverse Drug Reaction], myeloid differentiation factor 88/ec [Endogenous Compound], phosphatidylinositol 3 kinase/ec [Endogenous Compound], pomalidomide/ae [Adverse Drug Reaction], protein kinase C/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], suppressor of cytokine signaling/ec [Endogenous Compound], thalidomide/ae [Adverse Drug Reaction], thalidomide/cb [Drug Combination], thalidomide/cr [Drug Concentration], thalidomide/ip [Intraperitoneal Drug Administration], thalidomide/po [Oral Drug Administration], transcription factor Fli 1/ec [Endogenous Compound], transcription factor NFAT/ec [Endogenous Compound], transcription factor PU 1/ec [Endogenous Compound], transcription factor Sp1/ec [Endogenous Compound], Tumor necrosis factor alpha, vasculotropin/ec [Endogenous Compound], voltage gated chloride channel/ec [Endogenous Compound], large cell lymphoma, 5'-untranslated region, angiogenesis, antiangiogenic activity, antibody dependent cellular cytotoxicity, antiinflammatory activity, arachidonic acid metabolism, cell differentiation, chromosome 5, chromosome 5q, conceptual framework, drug blood level, drug dose escalation, embryotoxicity, epigenetics, Review

  19. 19
    Electronic Resource
  20. 20
    Electronic Resource